NCT00002902View on ClinicalTrials.gov

Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

April 30, 1997

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

irinotecan hydrochloride

DRUG

raltitrexed

Trial Locations (1)

19104

University of Pennsylvania Cancer Center, Philadelphia

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER